Among the 10 most active journals in SGLT2 inhibitor research, four were also among the top 10 co-cited journals (Diabetes Obesity and Metabolism, Diabetes Care, Cardiovascular Diabetology, and Circulation). This evidence concerns the gene SLC5A2 and diabetes mellitus.